Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Injectable Progesterone for Ovulation Triggering
NCT06928844Recruiting
- Sponsor
- General Authority for Teaching Hospitals and Institutes
- Start
- Apr 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of progesterone in infertility, sponsored by General Authority for Teaching Hospitals and Institutes. Primary endpoint: Incidence of ovulation rates. Started Apr 2025; status: recruiting.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06928844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06928844.